Rank | Gene Set | Z-score |
---|---|---|
1 | glutamate secretion (GO:0014047) | 5.76699002 |
2 | synaptic vesicle exocytosis (GO:0016079) | 5.56743357 |
3 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.30492645 |
4 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.28925538 |
5 | postsynaptic membrane organization (GO:0001941) | 5.25707588 |
6 | vocalization behavior (GO:0071625) | 5.19861077 |
7 | neuron cell-cell adhesion (GO:0007158) | 5.09904635 |
8 | histone H3-K4 trimethylation (GO:0080182) | 5.03935444 |
9 | synaptic vesicle maturation (GO:0016188) | 4.85171852 |
10 | detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580) | 4.58706660 |
11 | neurotransmitter secretion (GO:0007269) | 4.50438875 |
12 | transcytosis (GO:0045056) | 4.41422847 |
13 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.33725623 |
14 | presynaptic membrane assembly (GO:0097105) | 4.29599207 |
15 | presynaptic membrane organization (GO:0097090) | 4.23646848 |
16 | dopamine biosynthetic process (GO:0042416) | 4.22703710 |
17 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.17111342 |
18 | locomotory exploration behavior (GO:0035641) | 4.11898637 |
19 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.11650213 |
20 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.05950077 |
21 | mating behavior (GO:0007617) | 4.05082592 |
22 | dopamine transport (GO:0015872) | 4.01619095 |
23 | dendritic spine morphogenesis (GO:0060997) | 3.94363522 |
24 | establishment of mitochondrion localization (GO:0051654) | 3.86062804 |
25 | protein localization to synapse (GO:0035418) | 3.85315010 |
26 | gamma-aminobutyric acid transport (GO:0015812) | 3.82168270 |
27 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.78106847 |
28 | prepulse inhibition (GO:0060134) | 3.77355129 |
29 | neuron recognition (GO:0008038) | 3.76708344 |
30 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.76170648 |
31 | neurotransmitter transport (GO:0006836) | 3.73655993 |
32 | catecholamine transport (GO:0051937) | 3.69598447 |
33 | regulation of neurotransmitter levels (GO:0001505) | 3.66529522 |
34 | negative regulation of microtubule polymerization (GO:0031115) | 3.66379564 |
35 | regulation of synaptic vesicle transport (GO:1902803) | 3.65396732 |
36 | neuronal ion channel clustering (GO:0045161) | 3.61079306 |
37 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.58249795 |
38 | * regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.58021910 |
39 | layer formation in cerebral cortex (GO:0021819) | 3.56838231 |
40 | axonal fasciculation (GO:0007413) | 3.53197556 |
41 | cell fate commitment involved in formation of primary germ layer (GO:0060795) | 3.52643792 |
42 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.52414135 |
43 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.45495637 |
44 | gap junction assembly (GO:0016264) | 3.44956260 |
45 | * exploration behavior (GO:0035640) | 3.44612653 |
46 | regulation of synapse structural plasticity (GO:0051823) | 3.44504752 |
47 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.44251123 |
48 | positive regulation of dendritic spine development (GO:0060999) | 3.43911787 |
49 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.43691236 |
50 | membrane depolarization during action potential (GO:0086010) | 3.43618633 |
51 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.42965463 |
52 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.41464270 |
53 | neurofilament cytoskeleton organization (GO:0060052) | 3.40124012 |
54 | long-term memory (GO:0007616) | 3.37618626 |
55 | auditory behavior (GO:0031223) | 3.35592070 |
56 | neuron-neuron synaptic transmission (GO:0007270) | 3.35172932 |
57 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.35018600 |
58 | mitochondrion transport along microtubule (GO:0047497) | 3.34663714 |
59 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 3.34663714 |
60 | regulation of dopamine metabolic process (GO:0042053) | 3.32609233 |
61 | regulation of catecholamine metabolic process (GO:0042069) | 3.32609233 |
62 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.32298881 |
63 | neuronal action potential propagation (GO:0019227) | 3.30539769 |
64 | adult walking behavior (GO:0007628) | 3.29946057 |
65 | glutamate receptor signaling pathway (GO:0007215) | 3.28813127 |
66 | neurotransmitter biosynthetic process (GO:0042136) | 3.28147531 |
67 | cerebellar Purkinje cell layer development (GO:0021680) | 3.26105480 |
68 | alkaloid metabolic process (GO:0009820) | 3.20558690 |
69 | regulation of vesicle fusion (GO:0031338) | 3.19119662 |
70 | cerebellar granule cell differentiation (GO:0021707) | 3.18518521 |
71 | synaptic transmission, glutamatergic (GO:0035249) | 3.18332744 |
72 | behavioral response to cocaine (GO:0048148) | 3.16586804 |
73 | positive regulation of neurotransmitter transport (GO:0051590) | 3.16243351 |
74 | positive regulation of T cell cytokine production (GO:0002726) | 3.15530585 |
75 | proline transport (GO:0015824) | 3.15082199 |
76 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.12262662 |
77 | synaptic vesicle endocytosis (GO:0048488) | 3.12047914 |
78 | neuromuscular synaptic transmission (GO:0007274) | 3.10745191 |
79 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.08408156 |
80 | * membrane depolarization (GO:0051899) | 3.07198053 |
81 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.06804174 |
82 | regulation of neurotransmitter secretion (GO:0046928) | 3.06544738 |
83 | regulation of respiratory system process (GO:0044065) | 3.02950132 |
84 | neurotransmitter metabolic process (GO:0042133) | 3.00525486 |
85 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.98158735 |
86 | axon extension (GO:0048675) | 2.98014873 |
87 | cellular potassium ion homeostasis (GO:0030007) | 2.96963885 |
88 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.96657553 |
89 | cellular ketone body metabolic process (GO:0046950) | 2.95691745 |
90 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.95579150 |
91 | innervation (GO:0060384) | 2.90523069 |
92 | neuromuscular process controlling posture (GO:0050884) | 2.90287826 |
93 | response to auditory stimulus (GO:0010996) | 2.90032201 |
94 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.89188904 |
95 | synaptic vesicle transport (GO:0048489) | 2.86580656 |
96 | establishment of synaptic vesicle localization (GO:0097480) | 2.86580656 |
97 | activation of protein kinase A activity (GO:0034199) | 2.86406908 |
98 | response to pheromone (GO:0019236) | 2.86344986 |
99 | response to histamine (GO:0034776) | 2.86333933 |
100 | synapse assembly (GO:0007416) | 2.86252421 |
101 | regulation of neurotransmitter transport (GO:0051588) | 2.85786708 |
102 | sodium ion export (GO:0071436) | 2.84877623 |
103 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.84321509 |
104 | * membrane hyperpolarization (GO:0060081) | 2.83398207 |
105 | positive regulation of synapse assembly (GO:0051965) | 2.83165764 |
106 | response to amphetamine (GO:0001975) | 2.83155285 |
107 | regulation of synapse maturation (GO:0090128) | 2.83071075 |
108 | regulation of respiratory gaseous exchange (GO:0043576) | 2.81930522 |
109 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.81385306 |
110 | startle response (GO:0001964) | 2.81235541 |
111 | positive regulation of synapse maturation (GO:0090129) | 2.80112936 |
112 | axon ensheathment in central nervous system (GO:0032291) | 2.79843429 |
113 | central nervous system myelination (GO:0022010) | 2.79843429 |
114 | nucleobase catabolic process (GO:0046113) | 2.79236757 |
115 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.78962668 |
116 | short-term memory (GO:0007614) | 2.78587514 |
117 | synaptic transmission, dopaminergic (GO:0001963) | 2.78175315 |
118 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.77671259 |
119 | * regulation of postsynaptic membrane potential (GO:0060078) | 2.76857697 |
120 | cell differentiation in hindbrain (GO:0021533) | 2.76820096 |
121 | neuromuscular process controlling balance (GO:0050885) | 2.76140306 |
122 | glutamate metabolic process (GO:0006536) | 2.76108470 |
123 | learning (GO:0007612) | 2.74962583 |
124 | positive regulation of membrane potential (GO:0045838) | 2.73185462 |
125 | synapse organization (GO:0050808) | 2.72759215 |
126 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.72225729 |
127 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.71597316 |
128 | transmission of nerve impulse (GO:0019226) | 2.71039270 |
129 | dendrite morphogenesis (GO:0048813) | 2.70834094 |
130 | response to cocaine (GO:0042220) | 2.70000332 |
131 | cell migration in hindbrain (GO:0021535) | 2.69052202 |
132 | mechanosensory behavior (GO:0007638) | 2.68463427 |
133 | receptor clustering (GO:0043113) | 2.68208995 |
134 | response to insecticide (GO:0017085) | 2.67961667 |
135 | axon regeneration (GO:0031103) | 2.67942080 |
136 | ethanol oxidation (GO:0006069) | 2.65759935 |
137 | social behavior (GO:0035176) | 2.65737276 |
138 | intraspecies interaction between organisms (GO:0051703) | 2.65737276 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.08051817 |
2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.38823941 |
3 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 3.26953785 |
4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.93594198 |
5 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.87285476 |
6 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.76234465 |
7 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.54709977 |
8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.44050450 |
9 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.44050450 |
10 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.41730013 |
11 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.39284196 |
12 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.39217317 |
13 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.38867969 |
14 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.38817268 |
15 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.38252282 |
16 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.36447981 |
17 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.31384592 |
18 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.23097072 |
19 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.21860983 |
20 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.19744020 |
21 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.19272426 |
22 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.17054893 |
23 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.05273257 |
24 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.04622118 |
25 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.03239142 |
26 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.01729278 |
27 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.91230440 |
28 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.87851684 |
29 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.86015507 |
30 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.76728607 |
31 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.67306605 |
32 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.66113576 |
33 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.56281255 |
34 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.55706627 |
35 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.52045451 |
36 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.49874976 |
37 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.47502390 |
38 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.45857104 |
39 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.43416709 |
40 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.41271387 |
41 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.41028942 |
42 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.40598550 |
43 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.40580657 |
44 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.40440365 |
45 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.36716921 |
46 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.35203775 |
47 | TP53_16413492_ChIP-PET_HCT116_Human | 1.34627036 |
48 | * OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.33050575 |
49 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.33007832 |
50 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.32675982 |
51 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.31746359 |
52 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.29630856 |
53 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.26950851 |
54 | P300_19829295_ChIP-Seq_ESCs_Human | 1.26257200 |
55 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.25906700 |
56 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.23662748 |
57 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.23003969 |
58 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.22883421 |
59 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.22323156 |
60 | AR_25329375_ChIP-Seq_VCAP_Human | 1.21983653 |
61 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.20132461 |
62 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.18221056 |
63 | AR_19668381_ChIP-Seq_PC3_Human | 1.17834449 |
64 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.17829058 |
65 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.17634087 |
66 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.16814274 |
67 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.14145070 |
68 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.13047850 |
69 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.12529173 |
70 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.12138215 |
71 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.11288163 |
72 | STAT3_23295773_ChIP-Seq_U87_Human | 1.10602408 |
73 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.10220553 |
74 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.10121773 |
75 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.07883736 |
76 | VDR_22108803_ChIP-Seq_LS180_Human | 1.06131189 |
77 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.05646811 |
78 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.04724836 |
79 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.02749178 |
80 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.00683349 |
81 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.00526948 |
82 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.99742251 |
83 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.98931491 |
84 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.98255792 |
85 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.96822524 |
86 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.96625568 |
87 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.94513228 |
88 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.93419944 |
89 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.91886229 |
90 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.91566411 |
91 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.91512988 |
92 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.90959557 |
93 | JUN_21703547_ChIP-Seq_K562_Human | 0.90533703 |
94 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.90403065 |
95 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.90026053 |
96 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.89917136 |
97 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89808389 |
98 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.89143681 |
99 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88870659 |
100 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.88723196 |
101 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.88335563 |
102 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.87263007 |
103 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.86689647 |
104 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.85806750 |
105 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.85284115 |
106 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.85123472 |
107 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.83789798 |
108 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.83398901 |
109 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.83395438 |
110 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.82453250 |
111 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.81888713 |
112 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.81878384 |
113 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.81878384 |
114 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.80431076 |
115 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.80318735 |
116 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.79868676 |
117 | TCF4_23295773_ChIP-Seq_U87_Human | 0.79655848 |
118 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.77595990 |
119 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.75787839 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003880_abnormal_central_pattern | 5.03346858 |
2 | MP0004859_abnormal_synaptic_plasticity | 5.00152933 |
3 | * MP0003635_abnormal_synaptic_transmissio | 3.52471042 |
4 | MP0002139_abnormal_hepatobiliary_system | 3.51741759 |
5 | MP0001968_abnormal_touch/_nociception | 2.90431828 |
6 | MP0005423_abnormal_somatic_nervous | 2.81193645 |
7 | * MP0009745_abnormal_behavioral_response | 2.76833791 |
8 | MP0006276_abnormal_autonomic_nervous | 2.75345141 |
9 | * MP0002064_seizures | 2.72081280 |
10 | MP0002736_abnormal_nociception_after | 2.65930305 |
11 | MP0009046_muscle_twitch | 2.65291744 |
12 | * MP0002063_abnormal_learning/memory/cond | 2.64038523 |
13 | MP0004270_analgesia | 2.61818737 |
14 | MP0002822_catalepsy | 2.61601134 |
15 | MP0002734_abnormal_mechanical_nocicepti | 2.43943511 |
16 | MP0003122_maternal_imprinting | 2.42683051 |
17 | MP0001486_abnormal_startle_reflex | 2.42127121 |
18 | * MP0002572_abnormal_emotion/affect_behav | 2.29101302 |
19 | MP0001905_abnormal_dopamine_level | 2.13262922 |
20 | * MP0002272_abnormal_nervous_system | 2.10444800 |
21 | MP0002733_abnormal_thermal_nociception | 2.10240484 |
22 | MP0003252_abnormal_bile_duct | 2.07561079 |
23 | MP0002909_abnormal_adrenal_gland | 1.84754896 |
24 | MP0001529_abnormal_vocalization | 1.82178836 |
25 | MP0005386_behavior/neurological_phenoty | 1.81917034 |
26 | MP0004924_abnormal_behavior | 1.81917034 |
27 | MP0000778_abnormal_nervous_system | 1.78903947 |
28 | MP0002067_abnormal_sensory_capabilities | 1.77795597 |
29 | * MP0001440_abnormal_grooming_behavior | 1.74580039 |
30 | MP0001501_abnormal_sleep_pattern | 1.73705227 |
31 | * MP0001970_abnormal_pain_threshold | 1.68607837 |
32 | MP0003787_abnormal_imprinting | 1.68108223 |
33 | MP0002735_abnormal_chemical_nociception | 1.68016460 |
34 | MP0002557_abnormal_social/conspecific_i | 1.67197722 |
35 | MP0003300_gastrointestinal_ulcer | 1.57415472 |
36 | MP0002184_abnormal_innervation | 1.57275990 |
37 | MP0003329_amyloid_beta_deposits | 1.56689301 |
38 | MP0003879_abnormal_hair_cell | 1.52389895 |
39 | MP0004885_abnormal_endolymph | 1.52150041 |
40 | MP0009780_abnormal_chondrocyte_physiolo | 1.47314221 |
41 | MP0005360_urolithiasis | 1.46983477 |
42 | MP0004142_abnormal_muscle_tone | 1.45753876 |
43 | MP0004233_abnormal_muscle_weight | 1.45431515 |
44 | MP0004811_abnormal_neuron_physiology | 1.40304862 |
45 | MP0005085_abnormal_gallbladder_physiolo | 1.40258415 |
46 | MP0003123_paternal_imprinting | 1.36590665 |
47 | MP0001664_abnormal_digestion | 1.34666622 |
48 | MP0008872_abnormal_physiological_respon | 1.32410367 |
49 | MP0005646_abnormal_pituitary_gland | 1.30086443 |
50 | MP0008877_abnormal_DNA_methylation | 1.25428779 |
51 | MP0006292_abnormal_olfactory_placode | 1.24936116 |
52 | MP0004742_abnormal_vestibular_system | 1.22116515 |
53 | * MP0002066_abnormal_motor_capabilities/c | 1.22109778 |
54 | MP0002009_preneoplasia | 1.20260027 |
55 | MP0004858_abnormal_nervous_system | 1.19958349 |
56 | MP0001984_abnormal_olfaction | 1.19708479 |
57 | MP0002102_abnormal_ear_morphology | 1.19304168 |
58 | MP0008569_lethality_at_weaning | 1.17590257 |
59 | * MP0002882_abnormal_neuron_morphology | 1.14854560 |
60 | MP0002928_abnormal_bile_duct | 1.14534445 |
61 | MP0000955_abnormal_spinal_cord | 1.13289170 |
62 | MP0001986_abnormal_taste_sensitivity | 1.12989290 |
63 | MP0000566_synostosis | 1.09997623 |
64 | MP0001502_abnormal_circadian_rhythm | 1.09996390 |
65 | MP0003283_abnormal_digestive_organ | 1.07319224 |
66 | MP0002638_abnormal_pupillary_reflex | 1.02767523 |
67 | MP0001485_abnormal_pinna_reflex | 1.02296726 |
68 | MP0002876_abnormal_thyroid_physiology | 0.97988723 |
69 | MP0002653_abnormal_ependyma_morphology | 0.97421639 |
70 | MP0002837_dystrophic_cardiac_calcinosis | 0.97312276 |
71 | MP0000631_abnormal_neuroendocrine_gland | 0.96381424 |
72 | MP0003861_abnormal_nervous_system | 0.95807987 |
73 | MP0000751_myopathy | 0.94686005 |
74 | MP0005535_abnormal_body_temperature | 0.94532943 |
75 | MP0008961_abnormal_basal_metabolism | 0.94183522 |
76 | MP0005083_abnormal_biliary_tract | 0.93620413 |
77 | MP0005551_abnormal_eye_electrophysiolog | 0.93351348 |
78 | MP0003938_abnormal_ear_development | 0.92198093 |
79 | MP0005645_abnormal_hypothalamus_physiol | 0.91300612 |
80 | MP0004883_abnormal_blood_vessel | 0.91135099 |
81 | MP0002069_abnormal_eating/drinking_beha | 0.90939184 |
82 | MP0004133_heterotaxia | 0.89524657 |
83 | MP0008875_abnormal_xenobiotic_pharmacok | 0.89068900 |
84 | * MP0002152_abnormal_brain_morphology | 0.87608920 |
85 | MP0004145_abnormal_muscle_electrophysio | 0.86858764 |
86 | MP0000026_abnormal_inner_ear | 0.82735127 |
87 | MP0003890_abnormal_embryonic-extraembry | 0.82733964 |
88 | MP0000604_amyloidosis | 0.79316074 |
89 | MP0001764_abnormal_homeostasis | 0.78809963 |
90 | MP0003121_genomic_imprinting | 0.77108360 |
91 | MP0008874_decreased_physiological_sensi | 0.76897672 |
92 | MP0001177_atelectasis | 0.76550464 |
93 | MP0002229_neurodegeneration | 0.76223617 |
94 | MP0000569_abnormal_digit_pigmentation | 0.74910367 |
95 | MP0003632_abnormal_nervous_system | 0.74578966 |
96 | MP0010234_abnormal_vibrissa_follicle | 0.73985295 |
97 | MP0003866_abnormal_defecation | 0.73877016 |
98 | MP0005187_abnormal_penis_morphology | 0.73479655 |
99 | MP0005365_abnormal_bile_salt | 0.72771622 |
100 | * MP0003633_abnormal_nervous_system | 0.72579094 |
101 | MP0000049_abnormal_middle_ear | 0.72557121 |
102 | MP0005248_abnormal_Harderian_gland | 0.71405639 |
103 | MP0005499_abnormal_olfactory_system | 0.70975158 |
104 | MP0005394_taste/olfaction_phenotype | 0.70975158 |
105 | MP0001963_abnormal_hearing_physiology | 0.69393692 |
106 | MP0001188_hyperpigmentation | 0.69167294 |
107 | MP0002090_abnormal_vision | 0.69097187 |
108 | * MP0003631_nervous_system_phenotype | 0.68788880 |
109 | MP0010386_abnormal_urinary_bladder | 0.67425746 |
110 | MP0004130_abnormal_muscle_cell | 0.66311519 |
111 | MP0004043_abnormal_pH_regulation | 0.66146238 |
112 | MP0003195_calcinosis | 0.65894704 |
113 | MP0003868_abnormal_feces_composition | 0.65853407 |
114 | MP0003634_abnormal_glial_cell | 0.65570520 |
115 | MP0002751_abnormal_autonomic_nervous | 0.65561720 |
116 | MP0010770_preweaning_lethality | 0.63213625 |
117 | MP0002082_postnatal_lethality | 0.63213625 |
118 | MP0005332_abnormal_amino_acid | 0.63166904 |
119 | MP0003690_abnormal_glial_cell | 0.62765924 |
120 | MP0006035_abnormal_mitochondrial_morpho | 0.62732296 |
121 | MP0000920_abnormal_myelination | 0.62451942 |
122 | MP0005377_hearing/vestibular/ear_phenot | 0.61728040 |
123 | MP0003878_abnormal_ear_physiology | 0.61728040 |
124 | MP0002249_abnormal_larynx_morphology | 0.61487537 |
125 | MP0002752_abnormal_somatic_nervous | 0.60358552 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Limb dystonia (HP:0002451) | 5.83541733 |
2 | Focal motor seizures (HP:0011153) | 5.41231920 |
3 | Myokymia (HP:0002411) | 5.15079098 |
4 | Visual hallucinations (HP:0002367) | 4.84222459 |
5 | Pheochromocytoma (HP:0002666) | 4.50160611 |
6 | * Focal seizures (HP:0007359) | 4.40750066 |
7 | Hyperventilation (HP:0002883) | 4.40137909 |
8 | Neuroendocrine neoplasm (HP:0100634) | 3.82116525 |
9 | Progressive cerebellar ataxia (HP:0002073) | 3.50776874 |
10 | Epileptic encephalopathy (HP:0200134) | 3.37590885 |
11 | Generalized tonic-clonic seizures (HP:0002069) | 3.29761318 |
12 | Status epilepticus (HP:0002133) | 3.21629524 |
13 | Absence seizures (HP:0002121) | 3.11540270 |
14 | Volvulus (HP:0002580) | 3.10479848 |
15 | Agitation (HP:0000713) | 3.07880256 |
16 | Atonic seizures (HP:0010819) | 3.01192786 |
17 | Cerebral hemorrhage (HP:0001342) | 2.99908077 |
18 | Akinesia (HP:0002304) | 2.97950361 |
19 | Scanning speech (HP:0002168) | 2.95432430 |
20 | Broad-based gait (HP:0002136) | 2.85698866 |
21 | Polyphagia (HP:0002591) | 2.82591097 |
22 | Abnormal eating behavior (HP:0100738) | 2.82469587 |
23 | Diplopia (HP:0000651) | 2.82421682 |
24 | Abnormality of binocular vision (HP:0011514) | 2.82421682 |
25 | Sleep apnea (HP:0010535) | 2.81037212 |
26 | Supranuclear gaze palsy (HP:0000605) | 2.80874171 |
27 | Depression (HP:0000716) | 2.75670853 |
28 | Febrile seizures (HP:0002373) | 2.75580693 |
29 | Dialeptic seizures (HP:0011146) | 2.75452295 |
30 | Action tremor (HP:0002345) | 2.72580945 |
31 | Mutism (HP:0002300) | 2.72506617 |
32 | Torticollis (HP:0000473) | 2.72321167 |
33 | Truncal ataxia (HP:0002078) | 2.71791589 |
34 | Anxiety (HP:0000739) | 2.70879022 |
35 | Abnormality of proline metabolism (HP:0010907) | 2.69992095 |
36 | Hydroxyprolinuria (HP:0003080) | 2.69992095 |
37 | Cerebral inclusion bodies (HP:0100314) | 2.69444331 |
38 | Failure to thrive in infancy (HP:0001531) | 2.69265314 |
39 | Ankle clonus (HP:0011448) | 2.68159567 |
40 | Focal dystonia (HP:0004373) | 2.56219279 |
41 | Drooling (HP:0002307) | 2.55135215 |
42 | Excessive salivation (HP:0003781) | 2.55135215 |
43 | Gait imbalance (HP:0002141) | 2.52369220 |
44 | Craniofacial dystonia (HP:0012179) | 2.51263676 |
45 | Poor eye contact (HP:0000817) | 2.50727440 |
46 | Impaired social interactions (HP:0000735) | 2.49971918 |
47 | Abnormal social behavior (HP:0012433) | 2.49971918 |
48 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.48448206 |
49 | Metabolic alkalosis (HP:0200114) | 2.48083391 |
50 | Abnormality of the labia minora (HP:0012880) | 2.47863063 |
51 | Dysdiadochokinesis (HP:0002075) | 2.47006193 |
52 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.45603487 |
53 | Neonatal onset (HP:0003623) | 2.45338245 |
54 | Spastic tetraplegia (HP:0002510) | 2.44213923 |
55 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.41165077 |
56 | Abnormality of the parathyroid morphology (HP:0011766) | 2.39024736 |
57 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.38616778 |
58 | Amblyopia (HP:0000646) | 2.37812478 |
59 | Intention tremor (HP:0002080) | 2.36802512 |
60 | Urinary urgency (HP:0000012) | 2.35965943 |
61 | Lissencephaly (HP:0001339) | 2.35417774 |
62 | Bradykinesia (HP:0002067) | 2.33353052 |
63 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.33312384 |
64 | Hypoplasia of the brainstem (HP:0002365) | 2.33312384 |
65 | Amyotrophic lateral sclerosis (HP:0007354) | 2.32135187 |
66 | Epileptiform EEG discharges (HP:0011182) | 2.31863298 |
67 | EEG with generalized epileptiform discharges (HP:0011198) | 2.29617285 |
68 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.27782078 |
69 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.27782078 |
70 | Hepatoblastoma (HP:0002884) | 2.24887718 |
71 | Hypoventilation (HP:0002791) | 2.22783764 |
72 | Psychosis (HP:0000709) | 2.20007467 |
73 | Hypsarrhythmia (HP:0002521) | 2.18974585 |
74 | Hyperglycinuria (HP:0003108) | 2.18862366 |
75 | Postural instability (HP:0002172) | 2.18323695 |
76 | Papilledema (HP:0001085) | 2.17361694 |
77 | Spastic gait (HP:0002064) | 2.16862206 |
78 | Dysmetria (HP:0001310) | 2.16436600 |
79 | Progressive inability to walk (HP:0002505) | 2.16194661 |
80 | Abnormality of glycine metabolism (HP:0010895) | 2.15232540 |
81 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.15232540 |
82 | Retinal dysplasia (HP:0007973) | 2.14431768 |
83 | Pachygyria (HP:0001302) | 2.13364345 |
84 | Type II lissencephaly (HP:0007260) | 2.13191982 |
85 | Neurofibrillary tangles (HP:0002185) | 2.12407081 |
86 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.09442611 |
87 | Ventricular fibrillation (HP:0001663) | 2.05595363 |
88 | Abnormality of the lower motor neuron (HP:0002366) | 2.05458002 |
89 | Abnormality of the corticospinal tract (HP:0002492) | 2.03531442 |
90 | Specific learning disability (HP:0001328) | 2.01749230 |
91 | Cortical dysplasia (HP:0002539) | 2.00036427 |
92 | Gastroesophageal reflux (HP:0002020) | 1.99949965 |
93 | Deep venous thrombosis (HP:0002625) | 1.97502646 |
94 | Absent speech (HP:0001344) | 1.97481119 |
95 | Potter facies (HP:0002009) | 1.97426320 |
96 | Facial shape deformation (HP:0011334) | 1.97426320 |
97 | Termporal pattern (HP:0011008) | 1.97185396 |
98 | Insidious onset (HP:0003587) | 1.97185396 |
99 | Postural tremor (HP:0002174) | 1.96543326 |
100 | Obsessive-compulsive behavior (HP:0000722) | 1.96350867 |
101 | Methylmalonic aciduria (HP:0012120) | 1.94408995 |
102 | Delayed gross motor development (HP:0002194) | 1.94000410 |
103 | Poor suck (HP:0002033) | 1.93160988 |
104 | Gaze-evoked nystagmus (HP:0000640) | 1.92066780 |
105 | Rigidity (HP:0002063) | 1.91689761 |
106 | Gout (HP:0001997) | 1.90603610 |
107 | Vertebral clefting (HP:0008428) | 1.89134602 |
108 | Generalized myoclonic seizures (HP:0002123) | 1.86599700 |
109 | Exotropia (HP:0000577) | 1.84361801 |
110 | Hypoplasia of the corpus callosum (HP:0002079) | 1.84107201 |
111 | * Incomplete penetrance (HP:0003829) | 1.82256482 |
112 | Abnormality of salivation (HP:0100755) | 1.81891151 |
113 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.81626593 |
114 | Esotropia (HP:0000565) | 1.81310320 |
115 | Hemiparesis (HP:0001269) | 1.80518434 |
116 | Fetal akinesia sequence (HP:0001989) | 1.79855974 |
117 | Hemiplegia (HP:0002301) | 1.79590681 |
118 | Cerebral hypomyelination (HP:0006808) | 1.78498761 |
119 | Stereotypic behavior (HP:0000733) | 1.77746001 |
120 | Oligodactyly (hands) (HP:0001180) | 1.77404774 |
121 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.76530452 |
122 | Blue irides (HP:0000635) | 1.76235983 |
123 | Dyskinesia (HP:0100660) | 1.75493369 |
124 | Anosmia (HP:0000458) | 1.74847364 |
125 | Clonus (HP:0002169) | 1.74669753 |
126 | Increased circulating renin level (HP:0000848) | 1.74522972 |
127 | Genetic anticipation (HP:0003743) | 1.73956902 |
128 | Muscular hypotonia of the trunk (HP:0008936) | 1.73123165 |
129 | Shawl scrotum (HP:0000049) | 1.71042260 |
130 | Intellectual disability, severe (HP:0010864) | 1.70460132 |
131 | Optic nerve hypoplasia (HP:0000609) | 1.70125769 |
132 | Delusions (HP:0000746) | 1.69157441 |
133 | Lower limb muscle weakness (HP:0007340) | 1.66635235 |
134 | Impaired vibratory sensation (HP:0002495) | 1.66600474 |
135 | Megalencephaly (HP:0001355) | 1.65536920 |
136 | Abnormal pupillary function (HP:0007686) | 1.64889425 |
137 | Inappropriate behavior (HP:0000719) | 1.64309998 |
138 | Inability to walk (HP:0002540) | 1.64271101 |
139 | Intellectual disability, moderate (HP:0002342) | 1.60998474 |
Rank | Gene Set | Z-score |
---|---|---|
1 | NUAK1 | 3.61740824 |
2 | MARK1 | 3.34635158 |
3 | NTRK3 | 3.25042871 |
4 | DMPK | 3.04280942 |
5 | MAP3K12 | 2.97882501 |
6 | STK38L | 2.83784506 |
7 | MAP3K9 | 2.69845388 |
8 | MAP3K4 | 2.68507379 |
9 | MAP3K7 | 2.55246592 |
10 | RAF1 | 2.47703203 |
11 | PIK3CA | 2.40871430 |
12 | STK38 | 2.36874703 |
13 | EPHA4 | 2.32702653 |
14 | MINK1 | 2.29744936 |
15 | MAP2K7 | 2.14866597 |
16 | MAP2K4 | 2.07724078 |
17 | WNK3 | 2.06584826 |
18 | NTRK2 | 1.81332678 |
19 | PAK6 | 1.79575036 |
20 | KSR1 | 1.71268321 |
21 | GRK5 | 1.70977643 |
22 | MST4 | 1.70539085 |
23 | PINK1 | 1.55333987 |
24 | DAPK2 | 1.49652371 |
25 | CASK | 1.39923156 |
26 | PLK2 | 1.38424735 |
27 | EPHB2 | 1.35498301 |
28 | MAPK13 | 1.31027446 |
29 | PNCK | 1.27224288 |
30 | UHMK1 | 1.25713277 |
31 | OXSR1 | 1.22759794 |
32 | CSNK1G2 | 1.22463165 |
33 | CDK5 | 1.17724846 |
34 | KSR2 | 1.17503398 |
35 | ILK | 1.15076763 |
36 | NTRK1 | 1.14931004 |
37 | NEK6 | 1.12944745 |
38 | CAMKK2 | 1.11643488 |
39 | TEC | 1.06585631 |
40 | CDK18 | 1.04601427 |
41 | CDK15 | 1.03608591 |
42 | WNK4 | 1.03474709 |
43 | CSNK1G3 | 1.01707744 |
44 | CDK19 | 1.00996061 |
45 | TAOK1 | 1.00277409 |
46 | TNIK | 1.00075594 |
47 | RIPK4 | 0.98929986 |
48 | CDK14 | 0.96063837 |
49 | LATS2 | 0.95186210 |
50 | CAMKK1 | 0.94002760 |
51 | CDK11A | 0.91664907 |
52 | DAPK1 | 0.90251121 |
53 | SGK2 | 0.89206180 |
54 | ROCK2 | 0.89132437 |
55 | PKN1 | 0.88694454 |
56 | MAP3K11 | 0.88139453 |
57 | RET | 0.87738442 |
58 | PHKG1 | 0.86804919 |
59 | PHKG2 | 0.86804919 |
60 | TRIM28 | 0.86123771 |
61 | CAMK1 | 0.85258676 |
62 | PRKCG | 0.85105710 |
63 | CAMK2A | 0.82243930 |
64 | PAK3 | 0.80077342 |
65 | SIK2 | 0.79149619 |
66 | MAPK15 | 0.78081454 |
67 | MAP2K1 | 0.75763198 |
68 | PDK1 | 0.72784332 |
69 | STK39 | 0.72223458 |
70 | PDPK1 | 0.71814062 |
71 | EPHA3 | 0.71480048 |
72 | MAPKAPK5 | 0.70624534 |
73 | CAMK4 | 0.69218352 |
74 | SGK223 | 0.67691994 |
75 | SGK494 | 0.67691994 |
76 | DYRK1A | 0.65637909 |
77 | FGR | 0.65219884 |
78 | FES | 0.65209107 |
79 | CAMK1G | 0.64078395 |
80 | DYRK1B | 0.63735581 |
81 | TYRO3 | 0.63499819 |
82 | CAMK2B | 0.63187595 |
83 | MAPK12 | 0.60357017 |
84 | ROCK1 | 0.57974959 |
85 | CSNK1G1 | 0.57430530 |
86 | PRKD3 | 0.56415691 |
87 | MAP3K2 | 0.56021920 |
88 | DYRK3 | 0.55672621 |
89 | CAMK1D | 0.52141921 |
90 | STK11 | 0.52010825 |
91 | MAP2K2 | 0.51676012 |
92 | ERBB3 | 0.50569977 |
93 | PRKCE | 0.49389170 |
94 | SGK3 | 0.48859424 |
95 | PRKACB | 0.48658150 |
96 | RPS6KA2 | 0.48552502 |
97 | ALK | 0.47724070 |
98 | PRKCZ | 0.47325665 |
99 | TNK2 | 0.46717473 |
100 | PRKCH | 0.46172565 |
101 | LIMK1 | 0.43241323 |
102 | PRKACA | 0.42284562 |
103 | MARK2 | 0.41410803 |
104 | RPS6KA3 | 0.41169377 |
105 | CAMK2D | 0.40886346 |
106 | PRKG1 | 0.40783177 |
107 | PRKAA1 | 0.40148359 |
108 | CSNK1D | 0.39489466 |
109 | CDC42BPA | 0.39272959 |
110 | NEK1 | 0.38799041 |
111 | FER | 0.38482377 |
112 | DYRK2 | 0.38466557 |
113 | CSNK1A1 | 0.38406551 |
114 | ICK | 0.37912159 |
115 | LMTK2 | 0.37294636 |
116 | GRK6 | 0.36720614 |
117 | ERBB2 | 0.36696079 |
118 | SGK1 | 0.36650330 |
119 | CSNK1A1L | 0.36477642 |
120 | ADRBK2 | 0.36044896 |
121 | MAPK10 | 0.35427720 |
122 | NME1 | 0.35323765 |
123 | PRKCQ | 0.34950406 |
124 | BCR | 0.34355481 |
125 | BRSK1 | 0.34261269 |
126 | CSNK1E | 0.33619026 |
127 | PRKCB | 0.33609697 |
128 | CAMK2G | 0.32837956 |
129 | SCYL2 | 0.32661964 |
130 | PTK2B | 0.32004111 |
131 | FYN | 0.30786622 |
132 | MAPK8 | 0.30340156 |
133 | ARAF | 0.30293674 |
134 | FGFR2 | 0.28138413 |
135 | PRKCA | 0.25956119 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.54849449 |
2 | * Nicotine addiction_Homo sapiens_hsa05033 | 3.20838194 |
3 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.57551074 |
4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.42818187 |
5 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.32551401 |
6 | Cocaine addiction_Homo sapiens_hsa05030 | 2.31283651 |
7 | GABAergic synapse_Homo sapiens_hsa04727 | 2.28540619 |
8 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.14552525 |
9 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.03275879 |
10 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.03042273 |
11 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.98195852 |
12 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.96445153 |
13 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.89448438 |
14 | Circadian entrainment_Homo sapiens_hsa04713 | 1.87054553 |
15 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.86737239 |
16 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.84484141 |
17 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.83693666 |
18 | Long-term potentiation_Homo sapiens_hsa04720 | 1.72040903 |
19 | Morphine addiction_Homo sapiens_hsa05032 | 1.71590633 |
20 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.63579842 |
21 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.61085506 |
22 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.57193641 |
23 | Olfactory transduction_Homo sapiens_hsa04740 | 1.54621214 |
24 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.52886723 |
25 | Insulin secretion_Homo sapiens_hsa04911 | 1.49575894 |
26 | Parkinsons disease_Homo sapiens_hsa05012 | 1.47123787 |
27 | * Cholinergic synapse_Homo sapiens_hsa04725 | 1.46625979 |
28 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.45786620 |
29 | Salivary secretion_Homo sapiens_hsa04970 | 1.38749323 |
30 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.35487633 |
31 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.25162236 |
32 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.21764302 |
33 | Taste transduction_Homo sapiens_hsa04742 | 1.21106040 |
34 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.19713664 |
35 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.17718342 |
36 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.16762356 |
37 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.16360562 |
38 | Alzheimers disease_Homo sapiens_hsa05010 | 1.11474599 |
39 | Long-term depression_Homo sapiens_hsa04730 | 1.06500944 |
40 | Renin secretion_Homo sapiens_hsa04924 | 1.06484832 |
41 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.01906889 |
42 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.01647389 |
43 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.01268896 |
44 | Bile secretion_Homo sapiens_hsa04976 | 1.01078854 |
45 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.00943285 |
46 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.00541369 |
47 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.99853677 |
48 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.98791688 |
49 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.98199247 |
50 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.97312208 |
51 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.96828575 |
52 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.96408681 |
53 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.95440273 |
54 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.93932667 |
55 | Gap junction_Homo sapiens_hsa04540 | 0.92680389 |
56 | Carbon metabolism_Homo sapiens_hsa01200 | 0.90148250 |
57 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.90116317 |
58 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.89868519 |
59 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.88068242 |
60 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.86651384 |
61 | Prion diseases_Homo sapiens_hsa05020 | 0.86361542 |
62 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.85744910 |
63 | Axon guidance_Homo sapiens_hsa04360 | 0.82609853 |
64 | * Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.82596527 |
65 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.82005674 |
66 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.79450421 |
67 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.76658454 |
68 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.75558496 |
69 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.75165024 |
70 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.74349185 |
71 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.71914220 |
72 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.71345826 |
73 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.69681037 |
74 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.69195105 |
75 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.68193186 |
76 | Circadian rhythm_Homo sapiens_hsa04710 | 0.67943244 |
77 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.67763878 |
78 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.65815933 |
79 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.65008240 |
80 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.64509490 |
81 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.63936088 |
82 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.63292231 |
83 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.63156533 |
84 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.61771499 |
85 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.57839121 |
86 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.57810415 |
87 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.56647361 |
88 | Endometrial cancer_Homo sapiens_hsa05213 | 0.55277874 |
89 | Huntingtons disease_Homo sapiens_hsa05016 | 0.54795997 |
90 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.53588641 |
91 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.53493213 |
92 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.53127310 |
93 | Retinol metabolism_Homo sapiens_hsa00830 | 0.49871107 |
94 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.49703495 |
95 | Melanogenesis_Homo sapiens_hsa04916 | 0.49130412 |
96 | Phototransduction_Homo sapiens_hsa04744 | 0.49104036 |
97 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.48844946 |
98 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.48265569 |
99 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.45999679 |
100 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.44188872 |
101 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.43201225 |
102 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.42750961 |
103 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.42465276 |
104 | Alcoholism_Homo sapiens_hsa05034 | 0.41871788 |
105 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.40355470 |
106 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.39869213 |
107 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.38961816 |
108 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.38635830 |
109 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.38589674 |
110 | Histidine metabolism_Homo sapiens_hsa00340 | 0.38534441 |
111 | Glioma_Homo sapiens_hsa05214 | 0.38403238 |
112 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.37277561 |
113 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.37140302 |
114 | ABC transporters_Homo sapiens_hsa02010 | 0.36915116 |
115 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.36295792 |
116 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.35657826 |
117 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.35335741 |
118 | Adherens junction_Homo sapiens_hsa04520 | 0.34049709 |
119 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.32882821 |
120 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.32126597 |
121 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.31986826 |
122 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.31852396 |
123 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.30870232 |
124 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.30410555 |
125 | Tight junction_Homo sapiens_hsa04530 | 0.29724446 |
126 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.28583379 |
127 | Peroxisome_Homo sapiens_hsa04146 | 0.27539006 |